EHP Funds Inc’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,300
Closed -$211K 62
2024
Q3
$211K Buy
+1,300
New +$207K 0.13% 35
2024
Q2
Sell
-1,600
Closed -$253K 110
2024
Q1
$253K Sell
1,600
-500
-24% -$79.6K 0.1% 98
2023
Q4
$329K Buy
2,100
+100
+5% +$15.3K 0.12% 103
2023
Q3
$312K Sell
2,000
-1,300
-39% -$215K 0.15% 115
2023
Q2
$546K Sell
3,300
-1,100
-25% -$178K 0.13% 124
2023
Q1
$682K Buy
4,400
+1,200
+38% +$194K 0.13% 123
2022
Q4
$565K Sell
3,200
-800
-20% -$138K 0.11% 120
2022
Q3
$653K Sell
4,000
-500
-11% -$84.6K 0.13% 128
2022
Q2
$799K Sell
4,500
-1,370
-23% -$244K 0.13% 124
2022
Q1
$1.04M Buy
+5,870
New +$999K 0.17% 123

Other funds holding JNJ

EHP Funds Inc's JNJ Position: Q4 2024 in Review

EHP Funds Inc sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 1,300 shares — an estimated $211K sold.

EHP Funds Inc first reported a position in JNJ in Q1 2022 and held it in 10 quarters. The position peaked at $1.04M in Q1 2022. 4,105 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

  • EHP Funds Inc reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
  • EHP Funds Inc sold 1,300 Johnson & Johnson shares in Q4 2024, an estimated $211K.
  • EHP Funds Inc first reported a position in Johnson & Johnson in Q1 2022 and held it in 10 quarters.
  • EHP Funds Inc's Johnson & Johnson position peaked at $1.04M in Q1 2022.
  • 4,105 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on EHP Funds Inc's 13F filing for Q4 2024, filed 14 Feb 2025.